News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
No evidence for genetic link between height and testicular cancer
There is no evidence being tall causes an increased risk of testicular cancer, according to a new genetic analysis of more than 24,000 men.
Pioneering ‘precision’ radiotherapy boosts prostate cancer survival
A high-tech form of radiotherapy that shapes radiation beams to tumours can dramatically improve outcomes for patients with prostate cancer, long-term clinical trial results show.
New treatment approach for rare type of ‘triple negative’ breast cancers identified
Leading scientists funded by Breast Cancer Now have identified a potential new treatment approach for some ‘triple negative’ breast cancers (TNBCs).
Blood test could predict response of HPV-positive head and neck cancer to treatment
Researchers have developed a blood test that can detect whether patients with a type of locally advanced (non-metastatic) head and neck cancer have residual tumours after chemotherapy and radiotherapy.
ICR reacts to decision to make the immunotherapy nivolumab available on the Cancer Drugs Fund for non-small cell lung cancers
The ICR responds to the announcement by NICE that the immunotherapy nivolumab (Opdivo) will now be made available on the Cancer Drugs Fund for non-small cell lung cancers.
Whole-body scans benefit people with highest inherited cancer risk
People with a gene mutation that confers a very high risk of cancer would benefit from a whole-body MRI scan to detect the disease early, a new study reports.
Testing metabolites in blood predicts success of skin cancer treatment
Testing for a panel of metabolites in the blood can pick out which patients are likely to respond to a drug for skin cancer, new research reports.
The ICR pays tribute to researcher James Morden
The Institute of Cancer Research, London, has paid tribute to the life of James Morden, a senior medical statistician in the Clinical Trials and Statistics Unit (ICR-CTSU), who was tragically killed at the weekend.
New software can correct systematic 'batch effects' error in research data
Researchers have developed a new way to identify and correct for a type of systematic statistical error, known as 'batch effects', in large datasets.
ICR responds to Government’s policy paper on science and innovation after Brexit
The Institute of Cancer Research, London, has issued the following statement from Chief Executive Professor Paul Workman in response to a new policy paper by the Department for Exiting the European Union on the government's plans for science and innovation after Brexit.
New approach could better predict breast cancer risk due to family history
Scientists funded by Breast Cancer Now and Cancer Research UK have demonstrated a more accurate method to assess a woman’s familial risk of breast cancer, which could one day be added to existing models to help better predict an individual’s overall risk of breast cancer.
The ICR responds to Sir John Bell's Life Sciences Industrial Strategy
The Institute of Cancer Research, London, today responds to the publication of the Life Sciences Industrial Strategy. The ICR responded to the UK Government’s January 2017 green paper proposing how they intend to build a modern industrial strategy.
